Intrinsic Value

The intrinsic value of Ekso Bionics Holdings Inc (CHRN) under the Base Case is 14.67 USD per share. Compared with the current market price of 15.46 USD, the stock appears Overvalued by 5% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

CHRN Intrinsic Value
$14.67
Overvaluation 5%
Intrinsic Value
Price $15.46

CHRN is cheaper than usual. Still overvalued, but at its cheapest valuation in the past 5 years.

Monitor CHRN
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $11.74
Get notified when the price drops into your buy zone
Current Price $15.46
Intrinsic Value $14.67
Margin of Safety 20% $11.74
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to CHRN

Fundamental Analysis

What Ekso Bionics Does

Health Care

Ekso Bionics makes wearable robotic exoskeletons that help people move and lift more safely. Its main products are medical exoskeletons used in rehabilitation and therapy, and industrial exoskeletons used on the job to reduce strain on workers. The company sells into two broad markets: hospitals and rehab centers on one side, and employers in construction, manufacturing, and other physically demanding jobs on the other.

Headquarters
United States of America US
Employees
50
IPO date
Apr 10, 2013
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Ekso Bionics Holdings Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one CHRN stock?

The intrinsic value for Ekso Bionics Holdings Inc (CHRN) under the Base Case is 14.67 USD.

Is CHRN stock undervalued or overvalued?

Compared with the current market price of 15.46 USD, the stock appears Overvalued by 5% .

Back to Top